ENDRA Life Sciences (NASDAQ:NDRA) Shares Down 7.7%

Shares of ENDRA Life Sciences Inc. (NASDAQ:NDRA) traded down 7.7% on Tuesday . The stock traded as low as $0.26 and last traded at $0.27. 1,583,340 shares were traded during mid-day trading, an increase of 22% from the average session volume of 1,296,768 shares. The stock had previously closed at $0.29.

Wall Street Analysts Forecast Growth

Separately, Ascendiant Capital Markets cut their price objective on shares of ENDRA Life Sciences from $500.00 to $400.00 and set a “buy” rating for the company in a research report on Friday, June 7th.

ENDRA Life Sciences Trading Down 7.7 %

The stock has a market capitalization of $384,250.00, a price-to-earnings ratio of -0.21 and a beta of 0.81. The business has a 50 day simple moving average of $2.73 and a 200-day simple moving average of $16.02.

ENDRA Life Sciences (NASDAQ:NDRA) last released its quarterly earnings data on Wednesday, August 14th. The company reported ($0.08) EPS for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.01).

ENDRA Life Sciences Company Profile

ENDRA Life Sciences Inc develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.